Bicara Therapeutics Inc. BCAX

Set alert

8.96 USD +1.03 (+12.99%)

At closeNov 3, 2026, 5:42 PM EST

8.96 0.00 0.00%

After hours · Nov 3, 5:42 PM ET

7.90 Day range 9.48

7.87 52-week range 30.99

Held by insiders 10.07%

Held by institutions 102.47%

Float held by institutions 113.94%

Institutions 241

Top institutional holders
Holder	% held	Shares	Value	Reported
RA Capital Management, L.P.	10.97%	7,255,993	126.83M	Jun 29, 2026
T. Rowe Price Investment Management, Inc.	9.58%	6,338,487	110.80M	Jun 29, 2026
Siren, L.L.C.	8.47%	5,602,970	97.94M	Jun 29, 2026
Vestal Point Capital, LP	7.93%	5,250,000	91.77M	Jun 29, 2026
Deep Track Capital, Lp	6.20%	4,100,000	71.67M	Jun 29, 2026
Blackrock Inc.	5.82%	3,848,090	67.26M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
T. Rowe Price Small-Cap Stock Fund, Inc.	3.29%	2,179,330	38.09M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.53%	1,676,653	29.31M	Jun 29, 2026
T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd.	1.77%	1,170,492	20.46M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	1.73%	1,144,022	20.00M	Sep 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	1.65%	1,092,258	19.09M	Sep 29, 2026
TR PRICE-Price (T.Rowe) U.S. Small-Cap Core Equity Trust	1.52%	1,004,231	17.55M	Jun 29, 2026

BCAX insiders
Insider	Relation	Latest transaction	Date	Shares held
COHLHEPP RYAN	Chief Executive Officer	Conversion of Exercise of derivative security	Sep 7, 2026	181,641
HYEP IVAN	Chief Financial Officer	Conversion of Exercise of derivative security	Aug 9, 2026	129,855
MAZUMDAR CLAIRE	Chief Executive Officer	Conversion of Exercise of derivative security	Aug 9, 2026	362,152
MEISNER LARA S.	Officer	Conversion of Exercise of derivative security	Sep 28, 2025	0
RA CAPITAL MANAGEMENT, L.P.	Director and Beneficial Owner of more than 10% of a Class of Security	Purchase	Feb 25, 2026	0
RABEN DAVID M.D.	Officer	Conversion of Exercise of derivative security	Apr 26, 2026	55,286

Held by funds